🇫🇷
France · FR · FR:63975542
THALIDOMIDE BMS 50 mg, gélule
ATC L04AX02
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
CountryFR (France)
ATC codeL04AX02
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009572677662 plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène aluminium de 14 gélule(s)
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "63975542",
"date_amm": "2008-04-16",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/08/443",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L04AX02.
- GBMyrin 100mg tabletsLipomed GmbH
- GBTalidex 25mg tabletsSpecial Order
- 🇪🇸TALIDOMIDA ACCORD 50 MG CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- 🇪🇸TALIDOMIDA BMS 50 MG CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
- DKThalidomid "Accord"Accord Healthcare B.V.
- DKThalidomid LipomedLipomed GmbH
- DKThalidomide "Zentiva"Zentiva k.s.
- GBThalidomide 100mg tabletsSpecial Order
Access this data programmatically
Query THALIDOMIDE BMS 50 mg, gélule and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.